A randomized, open-label, multicenter, parallel-group study to compare the efficacy, safety and resource utilization of a remifentanil/propofol analgesia/sedation regimen versus a sufentanil/propofol analgesia/sedation regimen in mechanically ventilated intensive care patients requiring analgesia and sedation for up to 7 days
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Propofol; Remifentanil; Sufentanil
- Indications Pain
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 24 Jul 2007 Status changed from initiated to discontinued.
- 30 Jan 2007 New trial record.